Revolution Medicines' potential breakthrough pancreatic cancer drug succeeds in late-stage trial

EconomyDaily Composite

Revolution Medicines' drug for pancreatic cancer succeeded in a highly anticipated Phase 3 trial.

Source

CNBC

Opens original article in a new tab

Goldman Sachs has the top rank among the S&P 500 by this remarkable statistic

The investment bank has consistently rewarded its shareholders.

about 1 hour agoRead more →

Yahoo Finance

about 1 hour agoRead more →

CNBC

President Donald Trump has denied sending a bawdy 50th birthday letter to his then-friend Jeffrey Epstein at the request of Ghislaine Maxwell.

about 1 hour agoRead more →

CNBC

The U.S. blockade would apply to "any and all Ships trying to enter, or leave, the Strait of Hormuz," President Donald Trump said.

about 1 hour agoRead more →